A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

T

Tongji Hospital

Status

Completed

Conditions

Non-small Cell Lung Cancer

Treatments

Procedure: Sublobar dissection

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03427567
TJ-LC-01

Details and patient eligibility

About

A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer

Full description

This is a multi-centre real-world non-interventional observational study. The study data on patient demographic/tumor biological characteristics and clinical treatments were retrospectively collected to evaluate effectiveness of sublobar dissection in the Chinese patients with non-small cell lung cancer who received sublobar dissection.

Enrollment

3,902 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients >= 18 years old;
  • Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections);
  • Patients who received selective or systematic lymphadenectomy;
  • Pathologically diagnosed patients with non-small cell lung cancer;
  • Pathological staging: I, II

Exclusion criteria

  • Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies);
  • Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;

Trial design

3,902 participants in 1 patient group

Sublobar dissection
Description:
Chinese NSCLC patients who received sublobar dissection
Treatment:
Procedure: Sublobar dissection

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems